Disease/Infection News

RSS

Newly discovered mouse viruses can pave the way for future progress in hepatitis research

Newly discovered mouse viruses could pave the way for future progress in hepatitis research, enabling scientists to study human disease and vaccines in the ultimate lab animal.

9 Apr 2013

Research suggests number of dengue cases three times higher than current WHO estimate

"Around 390 million people are infected each year with dengue fever -- the world's fastest-spreading tropical disease -- more than triple the current estimate by the World Health Organization, experts said on Sunday," Reuters reports.

9 Apr 2013

Medicago, IDRI to present Phase I clinical results of H5N1 vaccine at World Vaccine Congress

IDRI, a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that they will be presenting positive interim Phase I clinical results for their H5N1 Avian Influenza VLP vaccine candidate "H5N1 vaccine" at the World Vaccine Congress.

9 Apr 2013

New Japan-driven initiative to accelerate research, development innovation for neglected diseases

The Drugs for Neglected Diseases initiative, based in Geneva, Switzerland, and DNDi Japan, based in Tokyo, welcome the launch of the Global Health Innovative Technology Fund, an initiative supported by the Japanese government, several Japanese pharmaceutical companies, and the Bill & Melinda Gates Foundation.

9 Apr 2013

Blogs, opinion pieces recognize 1,000 day milestone until end of MDGs

April 5 marked 1,000 days until the end of the Millennium Development Goals, agreed to by the U.N. in 2000 as the world's first development agenda. International discussions are underway to determine the post-2015 development agenda.

9 Apr 2013

Research findings could help develop effective vaccines against new strains of bird flu

Scientists have described small genetic changes that enable the H5N1 bird flu virus to replicate more easily in the noses of mammals.

9 Apr 2013

VOA News reports on pilot program against lymphatic filariasis in Nigeria

VOA News reports on "a new public health strategy, tested in Nigeria," which is "raising hopes" that the tropical disease known as lymphatic filariasis, or elephantiasis, can be eliminated.

9 Apr 2013

WHO considers sending experts to China as death toll from H7N9 virus hits 7

The WHO "is talking with the Chinese government about sending international experts to China to help investigate a new bird flu strain that has sickened at least 24 people, killing seven of them," the Associated Press reports.

9 Apr 2013

Clinical data of two Transgene products to be presented at EASL Conference

Transgene SA, a biopharmaceutical company that develops targeted immunotherapy products to treat major unmet medical needs in cancer and infectious diseases, today announced that favourable pre-clinical and clinical data on two Transgene products - TG1050 and TG4040 to treat chronic hepatitis B and chronic hepatitis C, respectively - will be presented in oral presentations at this year's European Association for the Study of the Liver Conference (Amsterdam, Netherlands, April 24-28, 2013).

9 Apr 2013

Blog summarizes discussion on HIV treatment for children under PEPFAR

The Center for Global Health Policy's "Science Speaks" blog describes "a public discussion [last] week of the Institute of Medicine's report" on PEPFAR, during which some experts raised the issue of HIV treatment for children.

9 Apr 2013

Anacor signs research agreement to discover drug candidates to treat neglected diseases

Anacor Pharmaceuticals today announced that it has signed a research agreement with the Bill & Melinda Gates Foundation (the Gates Foundation) to discover drug candidates intended to treat two filarial worm diseases (onchocerciasis, or river blindness, and lymphatic filariasis, commonly known as elephantiasis) and tuberculosis.

9 Apr 2013

MIT researchers present novel approach to develop dengue therapy using mutated antibodies

Nearly half of the world's population is at risk of infection by the dengue virus, yet there is no specific treatment for the disease. Now a therapy to protect people from the virus could finally be a step closer, thanks to a team at MIT.

9 Apr 2013

Gilead Sciences submits sofosbuvir NDA to FDA for treatment of chronic HCV infection

Gilead Sciences today announced that the company has submitted a New Drug Application to the U.S. Food and Drug Administration for approval of sofosbuvir, a once-daily oral nucleotide analogue for the treatment of chronic hepatitis C virus infection.

9 Apr 2013

Research: HIV women infected with HPV are not protected by current vaccines

Women with HIV acquire cancer-causing forms of the human papillomavirus (HPV) that are not included in the current HPV vaccines Gardasil and Cervarix, according to new research from Fox Chase Cancer Center being presented at the AACR Annual Meeting 2013 on Sunday, April 7.

8 Apr 2013

Phase 3 study results of simeprevir in hepatitis C patients to be presented at EASL Congress

Janssen R&D Ireland announces that data will be presented on the investigational protease inhibitor simeprevir (TMC435) for the treatment of hepatitis C at The International Liver Congress 2013 of the European Association for the Study of the Liver, which will take place April 24 to 28 in Amsterdam, The Netherlands.

8 Apr 2013

Abstracts on Bristol-Myers Squibb's research in liver disease accepted for presentation

Bristol-Myers Squibb Company announced today that 14 abstracts on the Company's research in liver disease have been accepted for presentation at The International Liver CongressTM 2013, the 48th annual meeting of the European Association for the Study of the Liver, in Amsterdam, April 24 - 28.

8 Apr 2013

Study creates first detailed, up-to-date map of dengue distribution worldwide

...

8 Apr 2013

FMT treatment improves symptoms in pediatric patients with active ulcerative colitis

A Spectrum Health clinical trial has found that fecal microbial transplantation (FMT) has resulted in the improvement or absence of symptoms in most pediatric patients with active ulcerative colitis.

7 Apr 2013

Student coalition ranks research universities' spending and activities on neglected diseases, other illnesses

"A first-time ranking of 54 top research universities in the United States and Canada has found that a miniscule percentage of funding goes to neglected diseases, despite the outsized influence that public universities play in developing medicines for illnesses often ignored by the private sector," Inter Press Service reports.

6 Apr 2013

USAID releases new issue of 'FrontLines'

The March/April issue of USAID's "FrontLines" focuses on access to safe water and neglected tropical diseases.

6 Apr 2013

Disease/Infection News

Newly discovered mouse viruses can pave the way for future progress in hepatitis research

Research suggests number of dengue cases three times higher than current WHO estimate

Medicago, IDRI to present Phase I clinical results of H5N1 vaccine at World Vaccine Congress

New Japan-driven initiative to accelerate research, development innovation for neglected diseases

Blogs, opinion pieces recognize 1,000 day milestone until end of MDGs

Research findings could help develop effective vaccines against new strains of bird flu

VOA News reports on pilot program against lymphatic filariasis in Nigeria

WHO considers sending experts to China as death toll from H7N9 virus hits 7

Clinical data of two Transgene products to be presented at EASL Conference

Blog summarizes discussion on HIV treatment for children under PEPFAR

Anacor signs research agreement to discover drug candidates to treat neglected diseases

MIT researchers present novel approach to develop dengue therapy using mutated antibodies

Gilead Sciences submits sofosbuvir NDA to FDA for treatment of chronic HCV infection

Research: HIV women infected with HPV are not protected by current vaccines

Phase 3 study results of simeprevir in hepatitis C patients to be presented at EASL Congress

Abstracts on Bristol-Myers Squibb's research in liver disease accepted for presentation

Study creates first detailed, up-to-date map of dengue distribution worldwide

FMT treatment improves symptoms in pediatric patients with active ulcerative colitis

Student coalition ranks research universities' spending and activities on neglected diseases, other illnesses

USAID releases new issue of 'FrontLines'

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News